z-logo
open-access-imgOpen Access
Balloon‐occluded retrograde transvenous obliteration for gastric varices improves hepatic functional reserve in long‐term follow‐up
Author(s) -
Waguri Nobuo,
Osaki Akihiko,
Watanabe Yusuke,
Matsubara Tsuyoshi,
Yamazaki Shun,
Yokoyama Hanako,
Kimura Kiwamu,
Wakabayashi Takuya,
Mito Masaki,
Yakubo Shunta,
Azumi Rie,
Kohisa Junji,
Takaku Kennichi,
Sato Munehiro,
Furukawa Kouichi
Publication year - 2021
Publication title -
jgh open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 8
ISSN - 2397-9070
DOI - 10.1002/jgh3.12675
Subject(s) - medicine , ascites , hepatic encephalopathy , gastroenterology , gastric varices , cirrhosis , albumin , balloon , surgery , varices
Background and Aim Balloon‐occluded retrograde transvenous obliteration (BRTO) has been widely adopted for the management of gastric fundal varices (GVs). There are a few reports that BRTO leads to the improvement of mid‐term and long‐term hepatic functional reserve (HFR). We retrospectively investigated the long‐term effect on HFR and prognosis among patients who had undergone BRTO for GVs. Methods This single‐center, retrospective study included 57successful patients out of 60 patients who underwent BRTO for GVs from December 2005 to September 2018. We examined the indicators of HFR (e.g., encephalopathy and ascites statuses, serum total bilirubin and albumin levels, % prothrombin time, and Child–Pugh and albumin–bilirubin [ALBI] scores) during 3 years of follow‐up after BRTO. We analyzed survival using the Kaplan–Meier method and identified the independent prognostic factors via multivariate analyses. Results GVs disappeared in all patients who were successfully treated by BRTO. At 3 years after BRTO, serum albumin levels were significantly elevated (from 3.3 to 4.0 g/dL, P  = 0.008), while Child–Pugh and ALBI scores were significantly decreased (from 7.0 to 5.7, P  = 0.043, and from −1.94 to −2.60, P  = 0.006, respectively). The median survival time among all patients was 2207 days; the survival rates after BRTO were 87.0% at 1 year, 81.8% at 3 years, 67.3% at 5 years, and 44.1% at 10 years. Multivariate analyses revealed that ascites, hepatic encephalopathy, and malignant neoplasms were independently associated with poor prognosis. Conclusion BRTO for GVs has a favorable effect on long‐term HFR.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here